Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid in the management of malignant pleural mesothelioma – feasibility study
2015-004433-26Phase 4Completed
- Sponsor
- North Bristol NHS Trust
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of zoledronic acid in pleural mesothelioma (2 arms), sponsored by North Bristol NHS Trust. Primary endpoint: Feasibility assessments. Started Mar 2016; status: completed.
02
Drugs
zoledronic acid
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on 2015-004433-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004433-26.